Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dr Anirvan Ghosh named head of discovery for CNS at Roche

This article was originally published in Scrip

Executive Summary

Roche has named Dr Anirvan Ghosh head of discovery for central nervous system (CNS). He will oversee discovery research in the CNS Disease and Translational Area with an emphasis on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression and neurodevelopment disorders. Dr Ghosh, who will relocate to Basel, Switzerland, joins Roche's Pharma Research and Early Development organisation from the University of California San Diego, where he has been the Stephen Kuffler professor of neurobiology since 2003; chair of the neurobiology section, division of biological sciences, since 2008; and co-director of the Center for Neural Circuits and Behavior since 2009.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC011962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel